THE BISPHOSPHONATE ZOLEDRONIC ACID DECREASES TUMOR GROWTH IN BONE IN MICE WITH DEFECTIVE OSTEOCLASTS

Bisphosphonates (BPs), bone targeted drugs that disrupt osteoclast function, are routinely used to treat complications of bone metastasis. Studies in preclinical models of cancer have shown that BPs reduce skeletal tumor burden and increase survival. Similarly, we observed in the present study that...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hirbe, Angela C., Roelofs, Anke J., Floyd, Desiree H., Deng, Hongju, Becker, Stephanie N., Lanigan, Lisa G., Apicelli, Anthony J., Xu, Zhiqiang, Prior, Julie L., Eagleton, Mark C., Piwnica-Worms, David, Rogers, Michael J., Weilbaecher, Katherine
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2782613/
https://ncbi.nlm.nih.gov/pubmed/19442620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2009.01.010
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares